Recrudescence of severe polyneuropathy after receiving Pfizer-BioNTech COVID-19 vaccine in a patient with a history of eosinophilic granulomatosis with polyangiitis

A middle age man with a history of diabetes mellitus type 2, hypertension, migraine and eosinophilic granulomatosis with polyangiitis (EGPA) with polyneuropathy in remission presented with paresthesia and motor weakness soon after receiving the Pfizer-BioNTech COVID-19 messanger RNA (mRNA) vaccine....

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Rahul, Rizvi, Macym, Sadiq, Muhammad S, Feldman, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Reports: Adverse drug reactions and complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058677/
https://www.ncbi.nlm.nih.gov/pubmed/35487626
http://dx.doi.org/10.1136/bcr-2021-245749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058677/
https://www.ncbi.nlm.nih.gov/pubmed/35487626
http://dx.doi.org/10.1136/bcr-2021-245749

Ejemplares similares